Monday, May 25, 2015
Current Weather
Loading Current Weather....
Published: Monday, 5/19/2014 - Updated: 1 year ago

Stocks edge higher as investors assess deal news

Pfizer, Abbott Laboratories gain


NEW YORK — Stocks are edging higher in midday trading as investors consider the latest news on corporate mergers.

Abbott Laboratories rose 2 percent after financial analysts cheered the medical device maker’s proposed acquisition of CFR Pharmaceuticals for nearly $3 billion.

Pfizer rose 1 percent after AstraZeneca’s board rejected Pfizer’s latest takeover offer. AstraZeneca sank 10 percent.

The Dow Jones industrial average rose 25 points, or 0.2 percent, to 16,516 in midday trading today.

The Standard & Poor’s 500 index rose five points, or 0.3 percent, to 1,883 and the Nasdaq composite rose 32 points, or 0.8 percent, to 4,123.

AT&T fell 1 percent after the company said it plans to buy satellite TV provider DirecTV for $48.5 billion. The proposal could face tough regulatory scrutiny. DirecTV also fell 1 percent.

Recommended for You

Guidelines: Please keep your comments smart and civil. Don't attack other readers personally, and keep your language decent. If a comment violates these standards or our privacy statement or visitor's agreement, click the "X" in the upper right corner of the comment box to report abuse. To post comments, you must be a Facebook member. To find out more, please visit the FAQ.

Related stories